Genomic Prediction

Genomic Prediction is a company incorporated in Delaware, operating as a biotechnology firm in North Brunswick, New Jersey. Founded in 2017, the company employs 28 individuals. Genomic Prediction specializes in providing advanced genomic tests designed to enhance the success rates of in vitro fertilization (IVF) procedures. Their tests focus on identifying genetic risks associated with chromosomal abnormalities, single-gene mutations, and polygenic diseases. These tests offer IVF parents a cost-effective way to assess the genetic health of their embryos. The company's testing methodology distinguishes itself through its use of dense, genome-wide genotyping methods and sophisticated, validation-focused modeling. This approach leverages the power of machine learning and large training datasets to provide a more accurate and comprehensive understanding of human genomic architecture and disease risk. For more information about Genomic Prediction and their services, please visit their website at genomicprediction.com.